373 related articles for article (PubMed ID: 37872285)
1. Metabolomic epidemiology offers insights into disease aetiology.
Fuller H; Zhu Y; Nicholas J; Chatelaine HA; Drzymalla EM; Sarvestani AK; Julián-Serrano S; Tahir UA; Sinnott-Armstrong N; Raffield LM; Rahnavard A; Hua X; Shutta KH; Darst BF
Nat Metab; 2023 Oct; 5(10):1656-1672. PubMed ID: 37872285
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic-guided discovery of Alzheimer's disease biomarkers from body fluid.
Enche Ady CNA; Lim SM; Teh LK; Salleh MZ; Chin AV; Tan MP; Poi PJH; Kamaruzzaman SB; Abdul Majeed AB; Ramasamy K
J Neurosci Res; 2017 Oct; 95(10):2005-2024. PubMed ID: 28301062
[TBL] [Abstract][Full Text] [Related]
3. An epidemiological introduction to human metabolomic investigations.
Joshi AD; Rahnavard A; Kachroo P; Mendez KM; Lawrence W; Julián-Serrano S; Hua X; Fuller H; Sinnott-Armstrong N; Tabung FK; Shutta KH; Raffield LM; Darst BF;
Trends Endocrinol Metab; 2023 Sep; 34(9):505-525. PubMed ID: 37468430
[TBL] [Abstract][Full Text] [Related]
4. Lessons and Applications of Omics Research in Diabetes Epidemiology.
Yu G; Tam HCH; Huang C; Shi M; Lim CKP; Chan JCN; Ma RCW
Curr Diab Rep; 2024 Mar; 24(3):27-44. PubMed ID: 38294727
[TBL] [Abstract][Full Text] [Related]
5. Combining mechanism-based prediction with patient-based profiling for psoriasis metabolomics biomarker discovery.
Wang Q; McCormick TS; Ward NL; Cooper KD; Conic R; Xu R
AMIA Annu Symp Proc; 2017; 2017():1734-1743. PubMed ID: 29854244
[TBL] [Abstract][Full Text] [Related]
6. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
Sun L; Li H; Lin X
J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic changes in vertebrate host during malaria disease progression.
Ghosh S; Pathak S; Sonawat HM; Sharma S; Sengupta A
Cytokine; 2018 Dec; 112():32-43. PubMed ID: 30057363
[TBL] [Abstract][Full Text] [Related]
8. Integration of metabolomics and proteomics in multiple sclerosis: From biomarkers discovery to personalized medicine.
Del Boccio P; Rossi C; di Ioia M; Cicalini I; Sacchetta P; Pieragostino D
Proteomics Clin Appl; 2016 Apr; 10(4):470-84. PubMed ID: 27061322
[TBL] [Abstract][Full Text] [Related]
9. Prospective Metabolomic Studies in Precision Medicine: The AKRIBEA Project.
Bizkarguenaga M; Gil-Redondo R; Bruzzone C; Bernardo-Seisdedos G; Laín A; González-Valle B; Embade N; Mato JM; Millet O
Handb Exp Pharmacol; 2023; 277():275-297. PubMed ID: 36253553
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics through the lens of precision cardiovascular medicine.
Lam SM; Wang Y; Li B; Du J; Shui G
J Genet Genomics; 2017 Mar; 44(3):127-138. PubMed ID: 28325553
[TBL] [Abstract][Full Text] [Related]
11. Metabolomic Biomarkers for Detection, Prognosis and Identifying Recurrence in Endometrial Cancer.
Njoku K; Sutton CJ; Whetton AD; Crosbie EJ
Metabolites; 2020 Jul; 10(8):. PubMed ID: 32751940
[TBL] [Abstract][Full Text] [Related]
12. Workshop report - interdisciplinary metabolomic epidemiology: the pathway to clinical translation.
Zanetti KA; Guo L; Husain D; Kelly RS; Lasky-Su J; Broadhurst D; Wheelock CE
Metabolomics; 2024 May; 20(3):60. PubMed ID: 38773013
[TBL] [Abstract][Full Text] [Related]
13. Metabolomics enables precision medicine: "A White Paper, Community Perspective".
Beger RD; Dunn W; Schmidt MA; Gross SS; Kirwan JA; Cascante M; Brennan L; Wishart DS; Oresic M; Hankemeier T; Broadhurst DI; Lane AN; Suhre K; Kastenmüller G; Sumner SJ; Thiele I; Fiehn O; Kaddurah-Daouk R;
Metabolomics; 2016; 12(10):149. PubMed ID: 27642271
[TBL] [Abstract][Full Text] [Related]
14. Design and analysis of metabolomics studies in epidemiologic research: a primer on -omic technologies.
Tzoulaki I; Ebbels TM; Valdes A; Elliott P; Ioannidis JP
Am J Epidemiol; 2014 Jul; 180(2):129-39. PubMed ID: 24966222
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of metabolomic biomarkers for cardiovascular disease risk: a systematic review and meta-analysis.
McGranaghan P; Saxena A; Rubens M; Radenkovic J; Bach D; Schleußner L; Pieske B; Edelmann F; Trippel TD
Biomarkers; 2020 Mar; 25(2):101-111. PubMed ID: 31928240
[No Abstract] [Full Text] [Related]
16. Exploration of variations in proteome and metabolome for predictive diagnostics and personalized treatment algorithms: Innovative approach and examples for potential clinical application.
Zhan X; Long Y; Lu M
J Proteomics; 2018 Sep; 188():30-40. PubMed ID: 28851587
[TBL] [Abstract][Full Text] [Related]
17. The role of metabolomic markers for patients with infectious diseases: implications for risk stratification and therapeutic modulation.
Zurfluh S; Baumgartner T; Meier MA; Ottiger M; Voegeli A; Bernasconi L; Neyer P; Mueller B; Schuetz P
Expert Rev Anti Infect Ther; 2018 Feb; 16(2):133-142. PubMed ID: 29316826
[TBL] [Abstract][Full Text] [Related]
18. Emerging Applications of Metabolomics in Clinical Pharmacology.
Pang H; Jia W; Hu Z
Clin Pharmacol Ther; 2019 Sep; 106(3):544-556. PubMed ID: 31173340
[TBL] [Abstract][Full Text] [Related]
19. Integrating Omic Technologies in Alzheimer's Disease.
Avramouli A; Vlamos PM
Adv Exp Med Biol; 2017; 987():177-184. PubMed ID: 28971457
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
